Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with (177)Lu-DOTATATE

Peptide receptor radiotherapy (PRRT) with (177)Lu-DOTATATE has emerged as a promising therapy for neuroendocrine tumors (NETs). This retrospective cohort study aimed to assess the outcome of PRRT for 22 patients with histopathologically confirmed pheochromocytoma (PCC) and paraganglioma (PGL), of wh...

詳細記述

保存先:
書誌詳細
出版年:Cancers (Basel)
主要な著者: Vyakaranam, Achyut Ram, Crona, Joakim, Norlén, Olov, Granberg, Dan, Garske-Román, Ulrike, Sandström, Mattias, Fröss-Baron, Katarzyna, Thiis-Evensen, Espen, Hellman, Per, Sundin, Anders
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2019
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6678507/
https://ncbi.nlm.nih.gov/pubmed/31261748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11070909
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料